Humanigen, Inc. retweeted
It's as if medicine agencies still haven't come to terms with the fact that SARS-CoV2 evolves ca 2.5x faster than the fastest evolving influenza strain. And that vaccine updates would have to be made twice as fast then as for influenza... teapaw.org/trvrb/status/151187159…
Replying to @trvrb
My main point was really how fast evolution has been proceeding. We see that SARS-CoV-2 variants have (1) displaced existing genetic diversity and (2) accumulated amino acid changes in the relevant domain much faster than seen in the fastest seasonal flu subtype H3N2. 2/13
Humanigen, Inc. retweeted
$HGEN New LIVE-AIR commentary published in ACP journals acpjournals.org/doi/10.7326/…
Humanigen, Inc. retweeted
$hgen is mentioned in this article posted by Reuters… Cameron was one of the 5…..
More big progress. I’d love to see them tweet about this on @humanigen
reuters.com/business/healthc…
Humanigen, Inc. retweeted
Eiger’s COVID-19 treatment reduces emergency room visits, death $EIGR bddy.me/3CPMuan
Humanigen, Inc. retweeted
Is COVID19 behind us?
This is not a time for Congress to cease funding COVID19 response & preparedness
MARCH 15 2021: 1244 Deaths per day
MARCH 15 2022: 1260 Deaths per day
Lets not fool ourselves, even w vaccines & immunity, this virus is ravaging us this year as much as last
Humanigen, Inc. retweeted
CDC estimates that BA.2 accounts for 23% of daily coronavirus cases in the U.S., up from 14% last week
Humanigen, Inc. retweeted
Since I praised South Korea's handling of COVID 4 months ago, I should also comment on the Covid crisis that is happening there now.
1) We see what omicron can truly do when it enters a country where very very few have had COVID before.
Humanigen, Inc. retweeted
I've been a a lot of epidemics -- on the ground, more than 30 -- and I've never seen anything like this curve.
Spread of #OmicronVariant in Southern Africa.
gisaid.org/hcov19-variants/
Humanigen, Inc. retweeted
NEW Research—Lenzilumab significantly improved survival without invasive mechanical ventilation in hospitalised patients with #COVID19
LIVE-AIR trial from Prof Zelalem Temesgen & colleagues bit.ly/31pMhw2
Humanigen, Inc. retweeted
We're delighted to announce that RATinG has now been submitted to REC/@HRA_Latest & @MHRAgovuk and we hope to receive approvals around the end of this year!
#GvHD #Lenzilumab @humanigen @AnthonyNolan @NHSBT @LeukUK @Becky_Bishop14
impactpartnership.org.uk/the…
Humanigen, Inc. retweeted
Kieron Lewis, our Director of Strategic Consulting, shares his point of view on access to #UnlicensedMedicines and who should pay when they are not provided for free.
Find out more: clinigengroup.com/our-story/…
Humanigen, Inc. retweeted
*Record high 466 COVID patients in Kentucky ICU* vaccines are crucial, therapeutics can be life saving too & keep people out of the hospital. Hoping the @US_FDA paves the way. #Lenzilumab can keep people off ventilators! 9 months ago it all started when my wife couldn’t breathe
😷MY #COVID19 JOURNEY😷
It was so difficult for me to write about something so personal, the night I thought the virus was going to kill me.
But, stories like mine need to be shared, so others realize just how vicious COVID-19 really is. @Norton_Health
nortonhealthcare.com/news/la…
Humanigen, Inc. retweeted
Why is this graph so concerning?
We're double the Delta wave peak of UK and Israel in hospitalizations and show no sign of letting up.
We'll hit 80,000 today and if we don't get slowing we'll exceed the 3rd wave peak of 125,000.
Never thought this would be possible with 💉💉
Humanigen, Inc. retweeted
From an idea in an article to a clinical trial for an experimental #COVID19 therapy in a year, all made possible by Mayo’s integrated medical and research efforts. Read more: mayocl.in/3w8xPC3
Humanigen, Inc. retweeted
Humanigen Inc. Added to Russell 3000(R) Index
Full Story: bit.ly/3A5WF8W
@humanigen $HGEN #Chemicals #Pharmaceutical #Pharmaceuticals #Medical #Biotechnology #NASDAQ #Investing
Humanigen, Inc. retweeted
Congratulations to our friends and partners at @humanigen on being added to the Russell 3000® Index!
newsfilecorp.com/release/889…
Humanigen, Inc. retweeted
Congratulations to our friends and partners at @humanigen on their initiation of a rolling review submission for Marketing Authorization by the @MHRAgovuk for their lead drug candidate, lenzilumab!
We have initiated submission for #lenzilumab for Conditional Marketing Authorization in COVID-19 to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) @MHRAgovuk
Read more:
businesswire.com/news/home/2…
































